aTyr Pharma, Inc.ATYRNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank23
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P23
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
2025-19.15%
2024-33.43%
2023-96.60%
20220.00%
2021-100.00%
20202377.49%
20190.00%
20180.00%
20170.00%
20160.00%